News

Julius Clinical at PCT 2017 Amsterdam

Posted on November 20, 2017

At PCT this year (27-29 November), Julius Clinical will have two people participating in a pre-conference workshop and a panel discussion. Make sure you are in the audience to hear what they have to say.

read more

Twenty more travel grants available for RSV Vaccines for the World, Málaga

Posted on August 09, 2017

We highly encourage junior or mid-stage career researchers and scientists/physicians from low and middle income countries to attend RSVVW. If you want be considered for a travel grant, please send an email with your details (country, current position, university) and abstract to info@resvinet.org to subscribe. Selection will be based on the quality of abstracts and geographic location of the author. Online registration is not needed. Please note that the deadline is September 1, 2017. Visit our website for more information.

read more

RSV Vaccines for the World Conference: Travel Grants Available

Posted on August 01, 2017

We are happy to inform you that we have travel grants for junior or mid-stage career researchers. EU awardees will receive 1000 Euro, non-EU awardees will receive 2000 Euro as a lump sum for all expenses. At least 20 travel grants will be available. Applicants are required to submit an abstract. If there are more applicants than available grants as of August 7, selection will be based on the quality of abstracts and geographic location of the author. After August 7, additional travel grants may be awarded based on availability of funds as well as abstract quality.

We highly encourage young researchers (specifically from low and middle income countries) to be part of RSV Vaccines for the World in November. If you want be considered for a travel grant, please send an email with your details (country, current title, university) and abstract to info@resvinet.org to subscribe. Online registration is not needed.  

read more

RSV Vaccines for the World Conference - registration open

Posted on July 25, 2017

We are delighted to announce that online registration is open for the RSV Vaccines For The World conference 2017.

The goal of the conference is to bring together the scientific data and expertise (mainly focusing on vaccine developments) and connecting the stakeholders involved in RSV research. Researchers and physicians from all over the world are invited to join the discussions and share their knowledge. Specifically, scientists and physicians from low- and middle income countries (LMICs) and young researchers are being encouraged and supported to participate in this meeting. This year, the conference will be held on 29 November-01 December in Malaga, Spain.

read more

Real world evidence in medicine development - sign up now

Posted on July 21, 2017

IMI’s GetReal project (www.imi-getreal.eu) will run the first edition of an interactive online course entitled ‘Real-world evidence in medicine development’ from 2 October to 12 November 2017. Under the supervision of leading academics from the project, the course will provide participants with an introduction to the topics covered by GetReal, and present the current techniques, opportunities and challenges for the use of real-world evidence in medicine development.

read more

Andrew Copestake joins Julius Clinical

Posted on May 05, 2017

Julius Clinical is proud to announce that Andrew Copestake has been appointed as our new Chief Business Development Officer starting immediately. He will be part of the Management team together with Messrs. Smink (CEO), Grobbee (CSO) and Van Dijk (COO).

read more

Julius Clinical Forms Alliance With Parexel

Posted on April 04, 2017

Alliance aims to strengthen global clinical trial services by aligning scientific and operational aspects of clinical trials

Utrecht, Netherlands, January 25, 2017 — Julius Clinical, a globally-operating Academic Research Organization (ARO), today announced it has entered into a non-exclusive alliance with PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation. The alliance provides biopharmaceutical companies an approach to aligning scientific and operational aspects of a clinical trial.

read more